Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Biotech

Biotech

Page 14 of 19

Big Pharma Innovation in Small Places

Big Pharma Innovation in Small Places

By Jennifer Alsever
May 13, 2016
Bioquark Cleared to Try and Revive Dead Brains
Tech

Bioquark Cleared to Try and Revive Dead Brains

By David Z. Morris
May 7, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By Sy Mukherjee
May 6, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By Sy Mukherjee
May 3, 2016
Celebrities At The Los Angeles Lakers Game
Finance

This Doctor Was Likely America’s Best Paid CEO in 2015

By Lucinda Shen
April 28, 2016
96436978
Tech

Why Microsoft Just Bought 10 Million Strands of DNA

By David Meyer
April 28, 2016
547016547
Health

Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop

By Sy Mukherjee
April 27, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

This Rare Children’s Disease Drug Is Pitting Patients Against the FDA

By Sy Mukherjee
April 26, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Rise With Oil After Best Weekly Gain Since November
Finance

Here’s Why Biogen’s Shares Are Climbing Today

By Sy Mukherjee
April 21, 2016
Here’s Why This Genetics Biotech’s Stock Plunged Today
Finance

Here’s Why This Genetics Biotech’s Stock Plunged Today

By Sy Mukherjee
April 19, 2016
Nick Annetta, right, of Battelle, watches as Ian Burkhart, 24, plays a guitar video game using his paralyzed hand. A computer chip in Burkhart`s brain reads his thoughts, decodes them, then sends signals to a sleeve on his arm, that allows him to move his hand.
Health

This Incredible Technology Let a Paralyzed Man Move His Hand

By Sy Mukherjee
April 14, 2016
BELGIUM-EU-AGRICULTURE-POLITICS
Health

FDA Says Pig Drug not Kosher Afterall

By Reuters
April 8, 2016
Key Speakers At The Hedge Funds Summit
Finance

Olive Garden Investor’s New Stock Pick Is This Biotech

By Reuters
April 8, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health

Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push

By Reuters
April 4, 2016
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
Health

The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs

By Reuters
March 29, 2016

Most Popular

  • Commentary
    Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
    By Daniel Bunn
  • Success
    Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets...
    By Preston Fore
  • Economy
    An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
    By Jim Edwards
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.